HBW Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

OTC Codeine Cough Syrups Meet UK Conditions For Rx Reverse Switch, Says Expert Body

Executive Summary

Could codiene linctus cough syrups be reverse-switched from OTC to Rx status in the UK? A panel of independent medicines experts suggests they should be, based on UK drugs law and their use in illegal cocktail Purple Drank.

You may also be interested in...



UK Weighing Reverse-Switch Of OTC Codeine Cough Syrups

UK consumers may soon lose OTC access to cough syrups containing codeine after MHRA said the products were increasingly being misused as an ingredient in an illegal recreational drink commonly named “Purple Drank.”

Ireland Reviewing Codeine's OTC Status

Ireland’s drug regulator HPRA has initiated a formal regulatory procedure to determine if OTC remains the appropriate classification for codeine-containing products. The agency says the move is in response to a growing understanding of the potential impacts of addiction to codeine at low doses.

Codeine/Ibuprofen Combination Drugs Should Be Rx-Only, Says EMA

Prompted by reports of abuse leading to deaths, the European Medicines Agency's PRAC is recommending that combination drugs containing codeine and ibuprofen be reverse-switched across the EU to prescription-only status.

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

RS153300

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel